SOLENO ONE
LIVE

Serial Number

98863148

Owner

Soleno Therapeutics, Inc.

Attorney

John Paul Oleksiuk

Filing Date

Nov 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SOLENO ONE Trademark

Serial Number: 98863148

SOLENO ONE is a trademark filed by Soleno Therapeutics, Inc. on November 20, 2024. The trademark is classified under Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Soleno Therapeutics, Inc.

100 Marine Parkway, Suite 400
Redwood City, CA 94065

Entity Type: 03

Trademark Details

Filing Date

November 20, 2024

Registration Date

Not Registered

Published for Opposition

July 8, 2025

Goods & Services

Providing information in the field of rare diseases and treatment thereof; Providing information in the fields of Prader-Willi syndrome, neurobehavioral diseases, metabolic diseases, endocrine diseases, and diseases characterized by hyperphagia, and the treatment thereof; Pharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve understanding by patients and caregivers about pharmaceuticals, providing resources to patients in the nature of product information for medical purposes, access to medication, informational materials and information regarding complying with instructions and directions for using medications and medical therapies

Providing a website featuring technology that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing an interactive website that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing online non-downloadable software for users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals

Business administration of patient pharmaceutical reimbursement programs; Business administration of a patient support and assistance program for obtaining reimbursement for prescription medicines

Communication services, namely, transmission of information relating to pharmaceuticals, medicine, and medical conditions and diseases via all means of telecommunication including the Internet

Financial administration of patient pharmaceutical reimbursement programs; Financial administration of a patient support and assistance program for obtaining reimbursement for prescription medicines

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 9, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 9, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 9, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 28, 2025 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Sep 17, 2025 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 4, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2025 CRFA
ASSIGNED TO LIE
Jun 2, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2025 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 21, 2025 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
May 21, 2025 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
May 21, 2025 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
May 21, 2025 CPEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2025 CNRT
ASSIGNED TO EXAMINER
May 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 19, 2025 ASCK
NEW APPLICATION ENTERED
Nov 20, 2024 NWAP